Andrew Abreo has been a participant in Advisory Boards with Horizon Therapeutics and Regeneron Pharmaceuticals.
Sara Anvari has received research funding from NIH/NIAID, American College of Allergy, Asthma and Immunology, and DBV Technologies. She has received consultancy fees from DBV. She serves on the medical advisory board for the International Food Protein-Induced Enterocolitis Syndrome (FPIES) Association.
Stuart Abramson is a member of the board of directors for the American Academy of Allergy, Asthma, and Immunology.
Marcella Aquino is the recipient of Grants from the American College of Allergy, Asthma and Immunology (ACAAI) Foundation Grant and Children’s Miracle Network Grants. She has received travel support from the American College of Allergy, Asthma and Immunology (ACAAI) and American Academy of Allergy, Asthma and Immunology (AAAAI), and the Brazil Allergy Society.
Theresa Bingemann is on the Board of Directors of the American Board of Allergy and Immunology, Board of Regents for the American College of Allergy, Asthma and Immunology, is a member of the Executive Committee for the AAP Section of Allergy and Immunology and the ACGME Allergy and Immunology Review Committee. She has been a speaker for Sanofi, consultant for ALK, Aimmune and Bryn. She served as a Principal Investigator on a Novartis trial.
Drew Bird is Chair and previous Executive Committee member of American Academy of Pediatrics, Section of Allergy and Immunology. He is a medical advisory board member for the International Food Protein-Induced Enterocolitis Syndrome (FPIES) Association. He has served as the Stock Epinephrine Advisory Committee Chair for the Texas Department of State Health Services. He has attended Advisory Boards for AllerGenis, Allergy Therapeutics, DBV Technologies, Food Allergy Research and Education (FARE), Genentech, and Novartis. He has been an Independent Study Monitor for Infinant Health. His institution has received payment for contracted research from Aimmune Therapeutics, DBV Technologies, Food Allergy Research and Education (FARE), Genentech, NIH/NIAID, Novartis, Regeneron and Siolta. He has served as a consultant for Allakos, HAL Allergy, Hanimmune Therapeutics, Nutricia and Parexel. He has been a Non-CME symposium speaker for DBV Technologies.
Terri Brown-Whitehorn has been a speaker, consultant, and Primary Investigator for DBV Technologies. She has been a sub-Investigator for a study for Regeneron. She worked with Food Allergy Research and Education (FARE) and NIH.
Bradley Chipps is an advisor for, received consultancy fees from, and is on the speakers’ bureau for Astra Zeneca, Regeneron, and Sanofi Genzyme.
Carla M. Davis has received research contract funding from DBV Technologies, Regeneron, Allergenis and Takeda, grant funding from the National Institute of Allergy and Infectious Disease (CoFAR and Consortium of Eosinophilic Gastrointestinal Disease Researchers), and the Food Allergy Research and Education. She has received educational funding from Takeda and Genentech.
Karla Davis holds stocks in Pfizer, Johnson and Johnson, Abbott and Abbvie.
Clinton Dunn served as speaker/consultant for ALK.
Alan Goldsobel has received research grants from Astra Zeneca, Areteia Therapeutics, Bellus, Cipla, Chiesi, Connect BioPharm LLC, Glaxo Smith Kline (GSK), DBV Technologies, IgGenix, Novartis, RAPT, Sanofi, and Teva. He been consultant for Takeda.
Ruchi Gupta receives research support from the National Institutes of Health (NIH) (R21 ID # AI135705, R01 ID # AI130348, U01 ID # AI138907), Food Allergy Research and Education (FARE), Melchiorre Family Foundation, Sunshine Charitable Foundation, Novartis, and Genentech. She serves as a medical consultant/advisor for Genentech, Novartis, Food Allergy Research and Education (FARE), OWYN, Kaléo, Aquestive Therapeutics, and Bryn Pharma. Dr. Gupta has ownership interest in Yobee Care, Inc.
Vivian Hernandez-Trujillo is a grant recipient from the Immune Deficiency Foundation. She has served as a consultant for Pharming, the National Peanut Board and Allergy and Asthma Network. She has received honoraria for speaking for the American College of Allergy, Asthma and Immunology (ACAAI), Food Allergy Research and Education (FARE), Allergy and Asthma Network and Enzyvant/Sumitomo (SMPA). She has participated in advisory boards for kaleo, CSL, Takeda, Bayer, Aimmune, Enzyvant/Sumitomo (SMPA), Pfizer, Sanofi/Regeneron, ARS, Bryn, and Genentech. She has served as a speaker for kaleo, Takeda, CSL, and Genentech. She is chair of the Practice Management Committee for American Academy of Allergy, Asthma, and Immunology (AAAAI) and previously served as a member of the AAP Section of Allergy and Immunology Executive Committee. She is part of the Immune Deficiency Foundation Medical Advisory Council. She has provided expert witness testimony on food allergy and anaphylaxis. She has received royalties from UpToDate. She represented the American College of Allergy, Asthma and Immunology on the Council of Pediatric Subspecialties as their representative and serves as an Assistant Editor for Allergy Watch.
Angela Hogan has participated on Speakers Bureau for Glaxo Smith Kline (GSK) and received honoraria for speaking from the American College of Allergy, Asthma, and Immunology and Asthma and Allergy Network. She has received support for travel from the American College of Allergy, Asthma, and Immunology (ACAAI) and AAP. She is the chair of the Asthma Committee of American College of Allergy, Asthma and Immunology (ACAAI), part of the AAP NCE Planning Group, American College of Allergy, Asthma and Immunology (ACAAI) annual meeting planning committee and FARE Neighborhood leadership for Hampton Roads.
Akilah Jefferson reports funding from the National Center for Advancing Translational Sciences of the National Institutes of Health under award number K12TR004924 and UM1TR004909.
Mitchell Lester reports organizational work with AAP, American Board of Allergy and Immunology, American College of Allergy, Asthma and Immunology (ACAAI), American Academy of Allergy, Asthma and Immunology (AAAAI), and NESA.
Lindsey Moore has been part of the Speakers Bureau for Aimmune and Genentech. She has received honorarium for speaker for AAP (Visiting Professor Program) and Allergy and Asthma Network. She has been a consultant for Regeneron and Kenota Health.
Christopher Parrish reports research support funds to the institution from NIH-NIAID, Regeneron Pharmaceuticals, and DBV Technologies. He has consulted with Magellan Rx. He had been a speaker for Sanofi Genzyme, and advisory board participation for Sanofi Genzyme and Takeda Pharmaceuticals.
Michael Pistiner has served on advisory boards of kaléo, DBV Technologies, Anjo, Food Graph, Bryan, Food Allergy Research and Education (FARE), Asthma and Allergy Foundation of America (AAFA), AAFA NE and Novartis, has received funding from AAFA, kaléo, DBV Technologies, Egg Nutrition Center, and the National Peanut Board, and is a cofounder of AllergyHome and of Allergy Certified Training.
Melinda Rathkopf has participated in advisory boards for Novartis and Sumitomo.
Marcus Shaker serves as part of the Joint Task Force, American College of Allergy, Asthma and Immunology (ACAAI), and American Academy of Allergy, Asthma and Immunology (AAAAI).
Scott Sicherer has received grants from NIAID/NIH, Pfizer, and Food Allergy Research and Education paid to his institution for research studies. He has received fees from the American Academy of Allergy, Asthma and Immunology as Deputy Editor of Journal of Allergy and Clinical Immunology- In Practice and royalties from UpToDate and Johns Hopkins U. Press.
Elinor Simons is a recipient of funding from the Canadian Institutes of Health Research and Advisory board of the DIVA Study.
David Stukus has been a Consultant for ARS Pharmaceuticals and Genentech. He has received research support from DBV Technologies. He serves as Associate Editor of Annals of Allergy, Asthma and Immunology, Social Media Editor for American Academy of Allergy, Asthma and Immunology (AAAAI). He has received honoraria from the American College of Allergy, Asthma and Immunology (ACAAI), AAP, Allergy & Asthma Network, and Food Allergy Research & Education (FARE).
Julie Wang has received royalties from UptoDate. Her institution has received grants for participation in clinical trials for Aimmune, DBV technologies and Siolta. She is a member of the American Board of Allergy and Immunology. She serves as Chair of the Annual Meeting Programming Committee for American Academy of Allergy, Asthma and Immunology. She is the immediate past chair of the Section of Allergy and Immunology for AAP.
Kelli Williams has been an Advisory Board Member & Speaker for Amgen. She has been an Advisory Board Member & Steering Committee Member for Pharming. She has been been an Advisory Board Member for Kenota Health. Her institution was paid for Principal Investigator role in Research by Glaxo Smith Kline (GSK). Principal Investigator of clinical trial for ADMA Biologics paid to her university. Sumitomo Advisory Board Participant. She was the Principal Investigator for a clinical trial paid to her institution by Cogent Biosciences.
The remainder of the authors have no disclosures to report.
Comments